← Eichor
Study identifier: NCT05912348 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults

Condition: Insulin Resistance · Impaired Glucose Tolerance · Obesity  ·  Sponsor: University of New Hampshire

PhaseNA
Planned participants45
Who can joinAll sexes, 18 Years to 30 Years
Healthy volunteersYes

About this study

This clinical trial aims to learn about the alterations in insulin resistance and metabolic flexibility following a transition to an obesogenic lifestyle in fit young men and women. The main questions it aims to answer are: 1. Does adding excess carbohydrates when transitioning to a sedentary lifestyle promote insulin resistance and impaired 24hr glucose regulation in healthy men and women? 2. Does adding excess carbohydrates when transitioning to a sedentary lifestyle lower the body's ability to break down fats and carbohydrates in healthy men and women? 3. Does the added physical activity blunt shifts in carbohydrate and fat oxidation in healthy men and women?

This description comes directly from the study's public registry record.

Talk to the study team

Michael Brian, PhD  ·  603-714-8899  ·  Michael.Brian@unh.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of New Hampshire Cardiometabolic Research LaboratoryDurham, New Hampshire, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05912348